Effect of Nurse-Led Remote Monitoring and Patient Navigation on Psychological Distress and Self-Management (remote monitor)
Effect of Nurse-Led Remote Monitoring and Patient Navigation on Psychological Distress and Self-Management Among Patients With Diabetes Mellitus
Diabetes mellitus is a chronic condition that often imposes significant psychological distress and requires complex daily self-management. This randomized controlled trial aims to evaluate the effectiveness of a structured nurse-led intervention combined with patient navigation on reducing psychological distress and improving self-management behaviors among patients with diabetes. Eligible adult patients with diabetes will be randomly assigned into either an intervention group receiving the nurse-led educational, psychosocial, and navigation support program alongside routine care, or a control group receiving routine diabetes care alone. Outcomes related to diabetes-related psychological distress and self-care adherence will be assessed at baseline and following the intervention period to determine the clinical impact of the program.
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Description détaillée
Background and Rationale:
Living with diabetes requires continuous lifestyle modifications, medication adherence, and blood glucose monitoring, which frequently lead to diabetes-related psychological distress, anxiety, and burnout. High levels of psychological distress negatively affect treatment adherence and glycemic control. Nurse-led interventions coupled with patient navigation offer a holistic, patient-centered approach by providing tailored health education, emotional support, problem-solving skills, and assistance in overcoming healthcare system barriers.
Study Objective:
The primary objective of this study is to examine the effect of a nurse-led intervention and patient navigation program on psychological distress and diabetes self-management among patients with diabetes.
Study Design and Methodology:
This study utilizes a two-arm, parallel-group randomized controlled trial (RCT) design. After obtaining informed consent and completing baseline assessments, eligible participants will be randomly allocated in a 1:1 ratio into two equal groups:
- Intervention Group: Participants will receive a structured nurse-led intervention and patient navigation program in addition to standard care. The intervention encompasses individualized diabetes self-management education, psychological and coping support, goal setting, care coordination, and regular follow-up reminders to facilitate access to healthcare services and address barriers to care.
- Control Group: Participants will continue to receive their standard routine diabetes care without the additional navigation or nurse-led sessions.
Outcome Assessment:
Both groups will be evaluated at baseline (pre-test) and after completion of the intervention (post-test) using validated psychometric and behavioral instruments measuring diabetes-related psychological distress (such as the Diabetes Distress Scale) and diabetes self-management practices (such as the Summary of Diabetes Self-Care Activities). Data will be statistically analyzed to compare pre- and post-intervention changes within and between the two study groups.
Type d'étude
Type d'étude
Inscription (Estimé)
Inscription
Phase
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
Coordonnées de l'étude
- Nom: Doaa mansour Ali, assisstant professor
- Numéro de téléphone: 01116240970
- E-mail: dodo8836@yahoo.com
Lieux d'étude
-
-
-
Cairo, Egypte
- Recrutement
- The study will be conducted at the Diabetes and Endocrinology Outpatient Clinics of Helwan General Hospital, a major secondary-level governmental healthcare facility operating under the Ministry of Health and Population in Cairo, Egypt.
-
Contact:
- Doaa mansour Ali, assisstant professor
- Numéro de téléphone: 01116240970
- E-mail: dodo8836@yahoo.com
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
Participants will be included in the study if they meet the following criteria:
- Adults aged 18 years or older.
- Patients with a confirmed diagnosis of type 1 or type 2 diabetes mellitus.
- Patients receiving routine diabetes care at the selected study setting.
- Patients who have access to a telephone or another suitable remote communication method.
- Patients who are willing to participate in the study and provide written informed consent.
- Patients who are able to understand and complete the study questionnaires in the selected validated language.
- Patients who are expected to be available throughout the intervention and follow-up period
Exclusion Criteria:
- Patients experiencing an acute medical condition requiring emergency treatment or hospitalization at the time of recruitment.
- Patients with severe cognitive impairment or communication difficulties that prevent meaningful participation in the intervention and completion of the assessment tools.
- Patients experiencing an acute psychiatric crisis requiring immediate specialized mental health intervention.
- Patients enrolled in another intensive remote diabetes-management program that could substantially overlap with the proposed intervention.
- Patients who decline participation or withdraw their informed consent. Note: A previous diagnosis of depression or anxiety should not automatically be an exclusion criterion unless justified by the study protocol. Including patients with stable mental health conditions may improve the applicability of the findings concerning psychological distress among diabetic patients.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Expérimental: Nurse led intervention and patient navigation
Participants will receive a nurse-led remote monitoring and patient navigation intervention aimed at supporting their psychological well-being and managing psychological distress over the intervention period. |
Nurse-led remote monitoring and patient navigation: refers to a structured, eight-week intervention delivered by a trained community health nurse through scheduled telephone calls or other agreed remote communication methods. It includes reviewing patients' reported health status, reinforcing diabetes self-management education, identifying barriers to healthcare access, facilitating appointments and referrals, and coordinating follow-up with healthcare providers. |
|
Aucune intervention: Usual care group
Participants will receive usual care without the nurse-led remote monitoring and patient navigation intervention. |
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
changes in psychological distress
Délai: 3 months
|
Assessment of changes in psychological distress among participants using the specified psychological distress assessment scale, comparing baseline and post-intervention measurements. |
3 months
|
|
Change in Diabetes Self-Management
Délai: 3 months
|
Assessment of changes in diabetes self-management among participants using the specified diabetes self-management assessment tool, comparing baseline and post-intervention measurements. |
3 months
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Les enquêteurs
Les enquêteurs
- Chercheur principal: Doaa MANSOUR Ali, ASSISSTANT PROFESSOR, Cairo University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Début de l'étude
Achèvement primaire (Réel)
Achèvement primaire
Achèvement de l'étude (Estimé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- HUNURSERC2026/10/67/14
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Individual participant data (IPD) collected during this study will not be shared with other researchers. The data will be used exclusively for the purposes of the current study and will be kept confidential to protect participants' privacy.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .